Drug Companies Spurned by Supreme Court on Price Negotiation Law
Source ↗
👁 1
💬 0
The US Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Medicare drug price negotiation program that’s led to billions of dollars in discounts on top-selling treatments.
Comments (0)